Shekar, P.V.; Kumar, A.; Mulgaonkar, N.; Kashyap, S.; Choudhir, G.; Fernando, S.; Rustgi, S.
Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent. Biomolecules 2025, 15, 805.
https://doi.org/10.3390/biom15060805
AMA Style
Shekar PV, Kumar A, Mulgaonkar N, Kashyap S, Choudhir G, Fernando S, Rustgi S.
Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent. Biomolecules. 2025; 15(6):805.
https://doi.org/10.3390/biom15060805
Chicago/Turabian Style
Shekar, Prasanna V., Anuj Kumar, Nirmitee Mulgaonkar, Samneet Kashyap, Gourav Choudhir, Sandun Fernando, and Sachin Rustgi.
2025. "Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent" Biomolecules 15, no. 6: 805.
https://doi.org/10.3390/biom15060805
APA Style
Shekar, P. V., Kumar, A., Mulgaonkar, N., Kashyap, S., Choudhir, G., Fernando, S., & Rustgi, S.
(2025). Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent. Biomolecules, 15(6), 805.
https://doi.org/10.3390/biom15060805